Particle News: Latest Glucagon-like peptide-1 receptor agonist news

Widespread Use of Weight-Loss Drugs Redefines Health, Beauty, and Access

Eli Lilly's Mounjaro Launches in India, Targeting Obesity and Diabetes

Eli Lilly Launches Mounjaro in India to Address Obesity and Diabetes

Rising Use of Ozempic Raises Health, Ethical, and Social Concerns

Eli Lilly Targets Unapproved Weight-Loss Drugs with New Ad Campaign

GLP-1 Weight Loss Drugs Surge in Popularity Amidst Stigma and Cultural Shifts

Hims & Hers Faces Stock Plunge After FDA Ends Semaglutide Shortage

UK Reports 82 Deaths Potentially Linked to Popular Weight-Loss Drugs

Jonathan Van Ness Reveals 66-Pound Weight Loss with GLP-1 Medication

GLP-1 Drugs Like Ozempic Show Promise in Reducing Cravings for Alcohol and Cocaine

Ozempic Shows Potential to Reduce Alcohol Consumption in Clinical Trial

Trump Administration Faces Backlash Over NIH and NSF Budget Cuts

Scientists Identify Brainstem Neurons That Signal When to Stop Eating

Pfizer Reports Strong Q4 Earnings But Faces Uncertain Market Sentiment

Novo Nordisk Reports Doubling Wegovy Sales, Projects Slower Growth in 2025

FDA Approves Ozempic to Reduce Kidney Disease Risks in Type 2 Diabetes Patients

FDA Approves Ozempic for Chronic Kidney Disease in Type 2 Diabetes Patients

Josh Gad Discusses 40-Pound Weight Loss Using GLP-1 Medication

Hims & Hers Debuts Super Bowl Ad Advocating for Affordable Weight-Loss Drugs

Allurion Technologies Stock Surges Following New Obesity Treatment Study Announcement

Novo Nordisk's Amycretin Shows 22% Weight Loss in Trial, Boosting Stock

Oprah Winfrey Reflects on Weight Loss Drugs and Misconceptions About Thin People

Study Reveals Broad Benefits and Risks of GLP-1 Weight-Loss Drugs

Study Highlights Benefits and Risks of Popular Weight-Loss Drugs

Study Maps Broad Health Impacts of Popular GLP-1 Weight-Loss Drugs

UnitedHealth CEO Addresses Systemic Issues Following Executive's Murder

Weight Loss Industry Transformed by New Drugs and Emerging Alternatives

GLP-1 Drugs Revolutionize Obesity Treatment While Raising Questions About Risks and Costs

Terry Smith Sells Diageo Stake Over Concerns About Weight-Loss Drugs' Impact

Weight Loss Drugs Reshape Food Industry and Consumer Habits

GLP-1 Drugs Show Promise Beyond Diabetes and Obesity but Raise Cost and Ethical Concerns

Elon Musk Promotes Weight-Loss Drug Mounjaro in Viral 'Ozempic Santa' Post

GLP-1 Drugs Revolutionize Prescriptions and Broader Health Applications

FDA Ends Shortage of Eli Lilly’s Weight-Loss Drug, Restricts Copycat Versions

Merck Secures $2 Billion Deal for Experimental Oral Weight Loss Drug from Hansoh Pharma

Nestle Introduces Protein Shot to Support Weight Loss and Hunger Management

Weight-Loss Injections Linked to Increased Fertility and 'Ozempic Babies'

Experts Explore Potential of Ozempic Microdosing for Health Beyond Weight Loss

Elon Musk and RFK Jr. Clash Over Weight-Loss Drug Policies

Eli Lilly Partners with Ro to Expand Access to Lower-Cost Zepbound Vials

Scams and Counterfeits Exploit Demand for Weight-Loss Drugs

Experts Urge Broader Approach to Obesity Beyond GLP-1 Drugs

Zepbound Outperforms Wegovy in Weight Loss Clinical Trial

Navigating Thanksgiving on Weight-Loss Drugs: Expert Advice on Food Choices

Biden Proposal for Medicare and Medicaid to Cover Weight-Loss Drugs Faces Uncertain Future Under Trump Administration

Diabetes and Obesity Drugs Found to Protect Kidney Health

Diabetes Drugs Show Potential in Reducing Alcohol Consumption

GLP-1 Medications See Surge in Use for Weight Loss and Potential Addiction Treatment

Al Roker Supports Use of Weight Loss Drugs, Citing Unique Challenges of Food Addiction

Nurse's Death Linked to NHS-Approved Weight-Loss Drug Mounjaro

Limited Access to Popular Weight-Loss Drugs Highlights Socioeconomic Disparities

Cost and Efficacy Concerns Arise for GLP-1 Weight Loss Drugs

Cost Concerns Limit Medicaid Coverage of Weight-Loss Drugs

Novo Nordisk Urges FDA to Ban Compounded Versions of Ozempic and Wegovy

Weight Loss Drugs Like Ozempic Show Promise in Treating Substance Use Disorders

Ozempic Shows Promising Mental Health and Cognitive Benefits

Study Links Weight Loss Drugs to Reduced Suicide Risk in Obese Teens

Senator Warren Urges FTC to Scrutinize Novo Holdings' $16.5B Catalent Acquisition

Eli Lilly Fights Back Against Compounded Tirzepatide Amid FDA Supply Resolution

Access to Popular Weight-Loss Drugs Faces Challenges Amid Cost and Coverage Issues

Boehringer Ingelheim's Survodutide Wins FDA Breakthrough Status for MASH Treatment

FDA Declares End to Tirzepatide Shortage, Impacting Compounded Drug Market

Wegovy and Ozempic: Celebrity Trends and Health Risks

WeightWatchers CEO Sima Sistani Steps Down Amid Struggles with Weight-Loss Drugs

Bernie Sanders and Elon Musk Unite on Lowering Ozempic Prices

Doctors Question Safety and Efficacy of GLP-1 Supplements and Drugs for Weight Loss

Pioneers of Obesity Drugs Win Prestigious Lasker Award

New Research Highlights Key Factors for Effective Weight Loss with GLP-1 Drugs

Study Identifies Key Factors Influencing Weight Loss on GLP-1 RA Medications

Kourtney Kardashian Launches Plant-Based Weight Loss Supplement 'Lemme GLP-1 Daily'

Kourtney Kardashian Launches Controversial GLP-1 Supplement

Novo Nordisk's Amycretin Pill Shows Promising Weight Loss Results in Early Trial

Lawsuit Highlights Severe Side Effects of Popular Weight-Loss Drugs

Semaglutide Shows Potential to Slow Aging and Reduce Mortality Rates

New Studies Confirm Safety of Semaglutide for Mental Health

New Study Links Ozempic to Increased Risk of Suicidal Thoughts

Eli Lilly's Q2 Earnings Surge on High Demand for Weight-Loss Drugs

Weight-Loss Drugs Reshape Health and Consumer Markets

GLP-1 Drug Shows Promise in Slowing Alzheimer's Cognitive Decline

Surge in GLP-1 Drugs for Weight Loss Sparks Concerns Over Diabetes Treatment

Ozempic's Expanding Role: Beyond Diabetes and Weight Loss

Roche's New Weight Loss Pill Shakes Up Pharmaceutical Market

Pfizer Advances Daily Weight Loss Pill Amid FDA Rejection of Novo's Insulin

Weight Loss Drug Adherence Drops, Companies Push for Oral Alternatives

GLP-1 Drugs Show Promise in Reducing Obesity-Related Cancer Risks

GLP-1 Drugs Show Promise in Reducing Risk of Multiple Obesity-Linked Cancers

Study Finds Exercise Essential to Counteract Bone Loss from Weight Loss Drugs

Food Giants Adjust Strategies for Weight-Loss Drug Users

WHO and Eli Lilly Warn of Dangerous Fake Weight-Loss Drugs

Novo Nordisk CEO to Testify on High US Drug Prices

Michigan's Largest Insurer Ends Coverage for Costly Weight-Loss Drugs

UK Approves Mounjaro for Obesity Treatment, Offering Alternative to Wegovy

Nestlé Adapts to Weight Loss Drug Trend with New Nutritional Products

Ro Launches GLP-1 Supply Tracker Amid Rising Drug Costs

Youth Prescriptions for Weight Loss and Diabetes Drugs Surge Nearly 600%

Sharp Increase in Weight-Loss Drug Use Among Teens and Young Adults

Nestlé Unveils Vital Pursuit: New Food Line for Weight-Loss Medication Users

Beyond Weight Loss: GLP-1 Drugs Show Promising Health Benefits

Innovative Weight-Loss Drug Targets Brain's Plasticity for Enhanced Effectiveness

Roche's Experimental Obesity Drug CT-388 Shows Significant Weight Loss in Early Trials